1 completed, 1 no longer available, 1 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow APT Pharmaceuticals, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CIS001 Extension Study of Cyclosporine Inhalation Solution Cyclosporine Inhalation Solution (CIS) - Lung Transplant | Phase 3 | Terminated | APT Pharmaceuticals, Inc. | 17 | 2009-12-01 | 2012-09-17 |
| Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation Cyclosporine Inhalation Solution (CIS) - Lung Transplant | Phase 3 | Completed | APT Pharmaceuticals, Inc. | 284 | 2008-09-01 | 2012-09-17 |
| Cyclosporine Inhalation Solution (CIS) in Lung Transplant Recipients Cyclosporine Inhalation Solution - Lung Transplant | No longer available | APT Pharmaceuticals, Inc. | 2012-09-17 |
Bronchiolitis Obliterans (3) · Bronchiolitis Obliterans Syndrome (2)
Cyclosporine (1)
United States (3) · Canada (2)
Bruce A Johnson, MD (1) · Jeffrey Golden, MD (1) · Stephen Dilly, MD PhD (1)